NDC to RxNorm Crosswalk 61958-1804 Harvoni

View RxNorm Concepts, RxCUIs, Term Types

RxNorm Crosswalk Information

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The RxNorm crosswalk for NDC code 61958-1804 indicates multiple RxNorm Concept Unique Identifiers known as RxCUIs associated to the product Harvoni . The unique RxCUI concepts linked to this product are: 1591943, 1591949, 2203895, 2203897, 2204100, 2204102, 2204103 and 2204104. RxCUIs are identifiers that group each chemically distinct drug into a single code regardless of manufacturer or package size. Drugs mapped to the same RxCUI are considered the same drug as having the same ingredients, strengths, and dose forms. The RxNorm mapping may include repeated RxCUI concepts with different descriptions and term types.

RxCUI: 1591943

Concept: ledipasvir 90 MG / sofosbuvir 400 MG Oral Tablet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: ledipasvir 90 MG / sofosbuvir 400 MG Oral Tablet: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

RxCUI: 1591949

Concept: Harvoni 90 MG / 400 MG Oral Tablet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: ledipasvir 90 MG / sofosbuvir 400 MG Oral Tablet [Harvoni]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Harvoni (ledipasvir 90 MG / sofosbuvir 400 MG) Oral Tablet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2203895

Concept: ledipasvir 45 MG / sofosbuvir 200 MG Oral Tablet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: ledipasvir 45 MG / sofosbuvir 200 MG Oral Tablet: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

RxCUI: 2203897

Concept: Harvoni 45 MG / 200 MG Oral Tablet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: ledipasvir 45 MG / sofosbuvir 200 MG Oral Tablet [Harvoni]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Harvoni (ledipasvir 45 MG / sofosbuvir 200 MG) Oral Tablet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2204100

Concept: ledipasvir 33.75 MG / sofosbuvir 150 MG per packet Oral Pellets: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: ledipasvir 33.75 MG / sofosbuvir 150 MG Oral Pellet: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

RxCUI: 2204102

Concept: Harvoni 33.75 MG / 150 MG per packet Oral Pellets: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: ledipasvir 33.75 MG / sofosbuvir 150 MG Oral Pellet [Harvoni]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Harvoni (ledipasvir 33.75 MG / sofosbuvir 150 MG) per packet Oral Pellets: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2204103

Concept: ledipasvir 45 MG / sofosbuvir 200 MG per packet Oral Pellets: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: ledipasvir 45 MG / sofosbuvir 200 MG Oral Pellet: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

RxCUI: 2204104

Concept: Harvoni 45 MG / 200 MG per packet Oral Pellets: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: ledipasvir 45 MG / sofosbuvir 200 MG Oral Pellet [Harvoni]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Harvoni (ledipasvir 45 MG / sofosbuvir 200 MG) per packet Oral Pellets: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

What is RxNorm?

RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.

The goal of RxNorm is to facilitate the efficient exchange of drug information among the computer systems used by hospitals, pharmacies, clinics and other organizations. To achieve this goal RxNorm provides normalized names and unique identifiers for drugs and medicines.

What is an RXCUI?

An RxCUI is machine readable unique identifier that defines the same common concept. Every name and code provided to the National Library of Medicine receives an RXCUI. Drug products that map to the same RxCUI are considered the same drug while drugs that are distinct will have different RxCUIs.

What is a Term Type (TTY)?

Term Types (TTYs) are used to specify the level of complexity of each RxCUI term.

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.